A recent single case publication showing that a patient with a presenilin 1 mutation was resistant to cognitive impairment, likely due to a homozygous mutation in APOE, supports the hypothesis that APOE might play an important role in this tau pathology acceleration (Arboleda-Velasquez et al., 2019). This evidence concerns the gene APOE and Cognitive impairment.